Raj Airey
Direttore/Membro del Consiglio presso Cytovation AS
Provenienza dei contatti di primo grado di Raj Airey
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Cytovation AS
 Cytovation AS Miscellaneous Commercial ServicesCommercial Services Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Raj Airey tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Oslo Cancer Cluster NCE
 Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Miscellaneous Commercial Services | Chairman | |
| AstraZeneca AS | Corporate Officer/Principal | ||
Holberg Fondsforvaltning AS
 Holberg Fondsforvaltning AS Investment ManagersFinance Holberg Fondsforvaltning AS (HF) is the wholly-owned fund management subsidiary of Norway-based Holberg Forvaltning AS, a holding company in which the founding partners are significant shareholders. Founded in 2000 by Gunnar J. Torgersen, Monica Mjøs Lassen, Inga Lise Lien Moldestad and Hogne I. Tyssøy, the firm is headquartered in Bergen and manages equity and fixed-income funds for individual and institutional investors. | Investment Managers | Chief Executive Officer | |
| University of Oslo | College/University | Doctorate Degree | |
| Norwegian School of Economics & Business Administration | College/University | Graduate Degree | |
Klaveness Chartering AS
 Klaveness Chartering AS Air Freight/CouriersTransportation Klaveness Chartering AS engages in shipping, brokerage, and trading. The company was founded on December 12, 1967 and is headquartered in Oslo, Norway. | Air Freight/Couriers | Director/Board Member | |
Utkilen AS
 Utkilen AS Trucks/Construction/Farm MachineryProducer Manufacturing Utkilen AS operates as a shipping company. The company has in-house functions for chartering, operations, ship management and crewing. The company was founded in 1967 and is headquartered in Bergen, Norway. | Trucks/Construction/Farm Machinery | Director/Board Member | |
| Nordisk Skibsrederforening | Director/Board Member | ||
| Boehringer Ingelheim Norway KS | Chief Tech/Sci/R&D Officer | ||
| ULTIMOVACS ASA | Pharmaceuticals: Major | Chief Executive Officer | |
Klaveness Ship Holding AS
 Klaveness Ship Holding AS Marine ShippingTransportation Klaveness Ship Holding AS engages in the provision of shipping services. It operates through the Combination Carriers and Container segments. The Combination Carriers segment transports both dry cargo and caustic soda in the Far East, the Middle East, Australia, Brazil, and North America. The Container segment owns and operates a fleet of eight geared container vessels in the feeder segment. The company was founded on May 30, 2005 and is headquartered in Oslo, Norway. | Marine Shipping | Director/Board Member | |
Curida AS
 Curida AS Pharmaceuticals: MajorHealth Technology Curida AS engages in the production of pharmaceutical products for other pharmaceutical companies, both in Norway and abroad. It manufactures and markets nasal and inhalation drug products. The company was founded in 1974 and is headquartered in Elverum, Norway. | Pharmaceuticals: Major | Director/Board Member | |
| Bristol-Myers Squibb Norway Ltd. | Chief Tech/Sci/R&D Officer | ||
| AIRTHINGS ASA | Electronic Equipment/Instruments | Director/Board Member | |
SKAGEN AS
 SKAGEN AS Investment ManagersFinance Part of Storebrand ASA, SKAGEN AS is a Norwegian fund management company. The company is based in Stavanger, Norway. SKAGEN was founded by Kristoffer Stensrud, Geir Tjetland, Åge Kristiansen Westbø, Tor Dagfinn Veen. Timothy Warrington has been the CEO of the company since 2007. | Investment Managers | Director/Board Member | |
| KLAVENESS COMBINATION CARRIERS ASA | Marine Shipping | Director of Finance/CFO | |
Klaveness AS
 Klaveness AS Other TransportationTransportation Torvald Klaveness is a shipping Norwegian company that is focused on safety and uses data to improve the nature of shipping. The private company is based in Oslo, Norway. and has subsidiaries in Singapore. The CEOs of the company are Lasse Kristoffersen, Ernst André Meyer. | Other Transportation | Director of Finance/CFO | |
| VITMED AS | Chief Executive Officer | ||
Hubro Therapeutics AS
 Hubro Therapeutics AS BiotechnologyHealth Technology Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway. | Biotechnology | Chairman |
Statistiche
Distribuzione geografica
| Norvegia | 20 |
Settori
| Transportation | 5 |
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 16 |
| Chief Executive Officer | 4 |
| Chairman | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Director of Finance/CFO | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Raj Airey
- Connessioni Società
